Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07363343 · ClinicalTrials.gov registry record · NA
Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study
A NA study, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07363343 is a NA study that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 200 participants.
The verdict
NCT07363343, a NA study, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
To determine if nifedipine and enalapril will have better blood pressure control in the postpartum setting compared to nifedipine and labetalol.
Interventions
- DRUG Nifedipine and Enalapril
- DRUG Nifedipine and Labetalol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-03-10 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07363343
The ClinicalTrials.gov registry entry for NCT07363343 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nifedipine and Enalapril is the first listed.
NCT07363343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07363343 about?
NCT07363343 is a clinical study titled "Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study". To determine if nifedipine and enalapril will have better blood pressure control in the postpartum setting compared to nifedipine and labetalol.
What is the current status of trial NCT07363343?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-03-10. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07363343?
The interventions under investigation include: Nifedipine and Enalapril (DRUG), Nifedipine and Labetalol (DRUG).
Who is sponsoring clinical trial NCT07363343?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.